| Document |
Document Title |
|
WO/2024/151728A1 |
A method for producing a fluorinated pillar metal-organic framework (MOF) materials is provided that avoids the need for high temperatures, and eliminates or substantially eliminates the need to use hydrofluoric acid. A reaction mixture ...
|
|
WO/2024/144090A1 |
The present invention relates to: a precursor for forming a metal-containing thin film, comprising a metal-containing compound represented by chemical formula 1; a method for forming a thin film using the precursor for forming a metal-co...
|
|
WO/2024/142881A1 |
This metal complex has Ir or Rh, the primary ligand of the metal complex being 1,4-di(pyridin-2-yl)benzene.
|
|
WO/2024/141067A1 |
A precursor material, the chemical structural formula of which is (I), wherein R1 and R2 are respectively mutually independent two-electron neutral ligands or R1 and R2 are four-electron neutral ligands linked to form a chain; R3 is one ...
|
|
WO/2024/139487A1 |
The embodiments of the present application disclose a composite material, and a light-emitting device and a preparation method thereof. The composite material comprises inorganic particles and a ligand, the ligand comprising a group cont...
|
|
WO/2024/140874A1 |
The present application discloses an iron complex, a preparation method therefor, a composition, a slurry, and a planarization method, and belongs to the technical field of surface treatment. The chemical formula of the iron complex is F...
|
|
WO/2024/142880A1 |
An organometallic complex represented by general formula (1). M is Pd or Pt. B-A-B is a tetradentate ligand comprising ring A and ring B bonded to each other. Ring A is a hydrocarbon aromatic ring or a heteroaromatic ring which may have ...
|
|
WO/2024/131235A1 |
The present invention relates to a spiro-containing platinum compound and an organic light-emitting device compound. The structure of the spiro-containing platinum compound is as shown in formula (I). Provided is a platinum compound of a...
|
|
WO/2024/137142A1 |
Provided is a method for inhibiting an infection of a cell by a coronavirus, including contacting the cell with an effective amount of a coordination compound represented by formula (I). Also provided is a method for preventing or treati...
|
|
WO/2024/126392A1 |
The present invention concerns vectorized iridium(III) complex with N- heterocyclic carbene-pyridine and a pharmaceutical composition comprising such a complex. The present invention also concerns their use for photodynamic therapy imple...
|
|
WO/2024/123570A1 |
Provided is a coordination compound represented by formula (I). Also provided is a pharmaceutical composition that can be used to treat cancers, including the coordination compound of formula (I) and a pharmaceutically acceptable carrier...
|
|
WO/2024/116908A1 |
This organometallic complex is characterized by being represented by general formula (1). (1): M(L1)m(L2)n In general formula (1), M represents Pt or Pd. M(L1) represents a structure represented by general formula (2) or (3). In gene...
|
|
WO/2024/113800A1 |
The present invention relates to an organic light-emitting diode material, a device and an apparatus. The phosphorescent material and the composition in the present invention have excellent chemical stability, and can improve and balance...
|
|
WO/2024/117630A1 |
The present invention relates to an iridium compound and a use thereof as a phosphorescent dopant for an organic electroluminescent device, and, more specifically, provides a novel iridium compound, a phosphorescent dopant for an organic...
|
|
WO/2024/115550A1 |
The present invention is directed to new compounds based on polyelectrophilic metalated heterocycles derived from 2-(pyridin-2-yl)imidazo[1,2-a]pyridine, to their obtaining procedure, as well as to their use as chemotherapeutic agents, i...
|
|
WO/2024/109935A1 |
The present disclosure relates to a gramine-platinum (IV) complex as well as a preparation method therefor and the anti-tumor use thereof. One gramine molecule is introduced to one side of the axial direction of a platinum (IV) coordinat...
|
|
WO/2024/103456A1 |
Provided are a catalyst for hydroformylation of olefins, a preparation method therefor, and use thereof. The catalyst comprises a metal center, a phosphoramidite ligand containing a carbazole group, and a monosubstituted phosphite ester....
|
|
WO/2024/105603A1 |
A Ruthenium (II) coordination compound: (III) where n is 0 or 2 and R is selected from the group consisting of: methyl; phenyl; -CH2NH2; -CH2OH; -COOH; an ester group -COOR1, an amide group -CONR2R3, for use as photosensitising agents in...
|
|
WO/2024/106218A1 |
The present disclosure provides an organic light-emitting element by including, in an organic compound layer, an organic metal complex which has a small full width at half maximum and high luminous efficiency by having, as the ligand, a ...
|
|
WO/2024/099888A1 |
The present invention relates to a process for converting an N-formyl-protected aminonitrile compound to the corresponding N-formyl-protected amino alcohol or amino alcohol compound or mixtures thereof by reductive hydrolysis in the pres...
|
|
WO/2024/103056A1 |
Composites, systems and methods are described herein enabling the profiling of local microenvironments across various biomolecular condensates via proximity labeling. In some embodiments, a composite includes one or more biomolecular con...
|
|
WO/2024/100067A1 |
Described herein is a dairy product, or a replica thereof, supplemented with a hemeprotein, and a method for preparing such a dairy product, or a replica thereof.
|
|
WO/2024/098677A1 |
The present invention belongs to the field of organic photoelectric materials. Disclosed are an organic metal compound, an organic electroluminescent device containing same and a use. The structural formula of the organic metal compound ...
|
|
WO/2024/099911A1 |
The present invention relates to iron carbonyl complexes of the general formula LFe(CO)3 (I), wherein L is a chiral, bidentate biphosphine ligand, to processes for preparing them and to their use as catalysts for hydrogenating olefins, f...
|
|
WO/2024/097945A1 |
The present technology is directed to a compound of Formula I: or a pharmaceutically acceptable salt and/or solvate thereof, and pharmaceutical compositions or medicaments comprising the compound. The compounds, pharmaceutical compositio...
|
|
WO/2024/093320A1 |
Disclosed are a complex, use thereof, an organic light-emitting element, and a display or lighting device. The complex has a structure represented by general formula (I) or general formula (I'), wherein (I) and (I') are enantiomers of ea...
|
|
WO/2024/097488A1 |
The present disclosure provides for catalytic transformation to convert ethylene and/or α-olefins to higher olefins. Specifically, this disclosure provides for methods of catalyzing alkene oligomerization reactions and the making of cat...
|
|
WO/2024/095863A1 |
The purpose of the present invention is to provide a metal-organic framework (MOF) which readily adsorbs a target substance even when under relatively low pressure. The present invention is a metal-organic framework constituted by specif...
|
|
WO/2024/095862A1 |
The purpose of the present invention is to provide an MOF which has excellent desorption performance. The present invention provides a metal organic framework which is composed of a specific organic ligand and a specific metal ion, where...
|
|
WO/2024/097160A1 |
Provided herein are certain transition metal complexes of formula (Ia), (Ib), (Ic), (Id), or (Ie). The transition metal complexes are suitable for use as MRI contrast agents and can be used for diagnosing the prognosis of cancer by measu...
|
|
WO/2024/087362A1 |
The present application provides a quaternary precursor, and a preparation method therefor and a use thereof. The preparation method comprises the following steps: (1) mixing a nickel source, a cobalt source, a manganese source, and an i...
|
|
WO/2024/092045A1 |
Methods of synthesizing diamine platinum(II) complexes and their conjugates are disclosed.
|
|
WO/2024/086535A2 |
The present application provides compounds and methods for iron replacement therapy.
|
|
WO/2024/086331A1 |
The present disclosure provides biochemically responsive Fe(II) and Fe(III) complexes useful as magnetic resonance imaging probes for diagnosis and monitoring acute and chronic inflammatory diseases affecting various organs and tissues.
|
|
WO/2024/085525A1 |
The present invention relates to an iridium complex, a photosensitizer, and a composition for photodynamic therapy and to an iridium complex, a photosensitizer, and a composition for photodynamic therapy wherein the iridium complex is po...
|
|
WO/2024/079091A1 |
The present invention relates to the field of biomass waste feedstock conversion into value-added chemicals. Specifically, the present invention relates to a method production of a chemical derived from biomass or derived from a biomass-...
|
|
WO/2024/028720A9 |
A bidentate phosphite ligand having the following structure: Formula (I) wherein each R1 group is an alkyl group or an aryl group and the two R1 groups bonded to the same phosphorus atom may be interconnected, wherein, when each R1 group...
|
|
WO/2024/078527A1 |
The present invention relates to the technical field of olefin polymerization catalysts, and discloses a phosphine-phenol late transition metal complex, and a preparation method therefor and the use thereof. The structural formula of the...
|
|
WO/2024/077554A1 |
The present invention sets forth a ligand and a preparation method therefor, a metal complex, a catalytic hydrogen production system, and a use thereof. The ligand has the structural formula (I), R being selected from (II) or (III). By m...
|
|
WO/2024/080842A1 |
The present invention relates to an organometallic compound and an organic electroluminescent device comprising same. The organometallic compound enables the manufacture of full-color displays and white light organic electroluminescent d...
|
|
WO/2024/073221A1 |
Provided is an optimized process for the synthesis of palladium(O) phosphine complexes. The process described herein is characterized by a more efficient reaction control, high yield and purity, the use of readily available starting mate...
|
|
WO/2024/071415A1 |
This catalyst composition for olefin polymerization contains a compound represented by general formula (A), and a transition metal compound represented by general formula (E) or (F). (The definitions in the general formulae are as descri...
|
|
WO/2024/062200A1 |
The invention relates to a method for producing a MOF, wherein a MOF is a structured metal-organic compound comprising a two- or three-dimensional porous network consisting of inorganic entities that are connected by polydentate chelatin...
|
|
WO/2024/052871A1 |
The object of the invention is a novel ruthenium complex of the general formula Ru-1, in which all the variable substituents have the meanings defined in the description. Also an object of the invention is a method for obtaining the ruth...
|
|
WO/2024/054394A1 |
Compositions and methods for treating oxidative stress, and conditions where oxidative stress contributes to conditions such as diabetes, in a subject by administering an effective amount of cobinamide. Oxidative stress can be caused by,...
|
|
WO/2024/050291A1 |
Supported catalysts contain a transition metal compound impregnated on or bound to a solid support, and the transition metal is iron, cobalt, or manganese. The solid support is an inorganic solid oxide or a chemically-treated solid oxide...
|
|
WO/2024/044271A2 |
Metal chelation compounds and associated coordination complexes are provided. In one aspect, this disclosure provides for a metal chelation compound, the compound having the general structure: D-L-T, wherein D is deferasirox or a derivat...
|
|
WO/2024/036656A1 |
The present invention provides an organometallic complex, a formulation, an organic optoelectronic device, and a display or lighting apparatus. The structure of the organometallic complex is as represented by formula I. The organic optoe...
|
|
WO/2024/033100A1 |
The present invention belongs to the field of nanoporous materials, in particular metal organic frameworks (MOFs) and Lewis-based gas delivery and/or slow release, or the detection of Lewis-based gas(es) in gases or liquid streams. The p...
|
|
WO/2024/034666A1 |
A ruthenium complex according to one aspect of the present disclosure is represented by general formula (1). In general formula (1), R1 represents a hydrogen atom, a phenyl group, or a monovalent substituent which is obtained by substitu...
|
